Puma Biotechnology Announces Collaboration With Strata Oncology To Accelerate Enrollment In Phase II SUMMIT trial Of PB272; SUMMIT Trial Evaluates Safety And Efficacy Of Neratinib In Patients With Solid Tumors With Mutations